Interleukin-3. Biologic effects and clinical impact.

Abstract

Human interleukin-3 (IL-3) is expressed in yeast and has a specific activity of 5 x 10(7) U/mg of protein. It exerts functional and proliferative effects on multiple hematopoietic cell lineages including the neutrophil, eosinophil, basophil, monocytic, and thrombopoietic cell lines. IL-3 and granulocyte-macrophage colony-stimulating factor (GM-CSF) share common binding capacities on hematopoietic cells. Each of these agents has entered clinical trials. The clinical experiences with IL-3 alone and in combination with GM-CSF in a Phase I/II trial are summarized in this report.

Statistics

0100200'95'98'01'04'07'10'13'16
Citations per Year

123 Citations

Semantic Scholar estimates that this publication has 123 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Oster1991Interleukin3BE, title={Interleukin-3. Biologic effects and clinical impact.}, author={W . Oster and J Frisch and Uwe Nicolay and Guido Schulz}, journal={Cancer}, year={1991}, volume={67 10 Suppl}, pages={2712-7} }